Delivery Order SPE2DB22D9244-SPE2DB24FZS61

Award Date 8/26/24
Potential Completion Date 9/17/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
The U.S. Defense Logistics Agency (DLA) awarded a $4,815.36 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with DLA to provide a wide range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,149.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564814368 Kyleena 19.5 mg systems, a contraceptive device. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which enables the DLA to issue firm fixed-price...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $27,022.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the contraceptive device Kyleena 19.5 mg Systems and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,203.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Kyleena, a 19.5 mg contraceptive system. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, which has a ceiling value of up to $4,999,999 and allows DLA to place orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $4,815.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of the Kyleena 19.5 mg contraceptive system. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB22D9207 with DLA, which is valued at up to $4,999,999 and enables the agency...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,751.58, is for the delivery of KYLEENA 19.5 MG SYSTEMS, a contraceptive implant product. This order is placed under a larger indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group with the DLA, valued at up to $4,999,999 through 2025. The IDV allows the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,171.86 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Kyleena 19.5 mg systems. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,419.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4565423461 KYLEENA 19.5 MG SYSTEMS and does not have a set-aside designation. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, which provides a wide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $2,859.15, is for the delivery of the pharmaceutical product Kyleena 19.5 MG Systems. This delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place orders for a wide range of branded and...
  • SPE2DB22D9244
    Indefinite Delivery Contract
  • SPE2DB22D9244-SPE2DB24FZS61
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $5,838.70, is for the procurement of the contraceptive device Kyleena. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities. The contract does not have a set-aside designation.

Generated 11/25/24, 9:15 AM